The XtremeCT II is the new generation high resolution peripheral quantitative computed tomography (HR-pQCT).
The XtremeCT II is designed to measure the bone density and to quantify the threedimensional microarchitecture of the bone at the distal tibia and radius of humans for clinical in vivo assessment of osteoporosis at an even higher precision and speed than its predecessor, the XtremeCT.
A low X-ray dose allows regular follow-up measurements and powerful true-3D evaluation software automatically matches cortical and trabecular bone regions to previous measurements for direct comparison of density and structure characteristics.
Density Parameters | Structural Parameters |
---|---|
Cortical Density | Trabecular Thickness |
Trabecular Density | Trabecular Separation |
Trabecular Number | |
Volume Fraction | |
Cortical Thickness | |
Cortical porosity |
For compatibility with the previous generation HR-pQCT, a XtremeCT equivalent protocol is available.
Specifications | |
---|---|
Type | High-resolution peripheral quantitative CT No external shielding required |
X-ray source | Sealed Closed water cooling system Maintenance-free 60 µm spot size 68 kVp, 100 W, cone beam |
Detector | 4608 x 400 elements CCD |
Resolution | ‹ 58 µm (10% MTF) 30 - 273 µm nominal isotropic (pixel size) |
Image matrix | 512 x 512 to 8192 x 8192 pixels |
Max. scan size | 140 mm x 225 mm (ØxL) |
Max. specimen size | 170 mm* (Ø)** |
Min. scan time | 30 s |
Electrical | 100 - 230 V / 50 - 60 Hz / 10A 370W |
Dimensions | 144 x 142 x 96 cm (HxWxD) |
Weight | 570 kg |
*Density calibration valid up to 140 mm **Scanner is open-ended |
Regulatory Information | |
---|---|
Canada | Medical Device (Health Canada License) |
European Union | Medical Device (MDR) |
Japan | Medical Device (JPAL) |
Switzerland | Medical Device (MDR) |
United Kingdom | Medical Device (MDR) |
USA | Research/Investigational Device |
For other countries please contact us about the current status.